These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38206637)

  • 1. Acute leukemia of ambiguous lineage with BCL11B rearrangement.
    Dimopoulos YP; Loghavi S
    Blood; 2024 Jan; 143(2):183. PubMed ID: 38206637
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancer Hijacking Drives Oncogenic
    Montefiori LE; Bendig S; Gu Z; Chen X; Pölönen P; Ma X; Murison A; Zeng A; Garcia-Prat L; Dickerson K; Iacobucci I; Abdelhamed S; Hiltenbrand R; Mead PE; Mehr CM; Xu B; Cheng Z; Chang TC; Westover T; Ma J; Stengel A; Kimura S; Qu C; Valentine MB; Rashkovan M; Luger S; Litzow MR; Rowe JM; den Boer ML; Wang V; Yin J; Kornblau SM; Hunger SP; Loh ML; Pui CH; Yang W; Crews KR; Roberts KG; Yang JJ; Relling MV; Evans WE; Stock W; Paietta EM; Ferrando AA; Zhang J; Kern W; Haferlach T; Wu G; Dick JE; Klco JM; Haferlach C; Mullighan CG
    Cancer Discov; 2021 Nov; 11(11):2846-2867. PubMed ID: 34103329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
    Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
    Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.
    Abbas S; Sanders MA; Zeilemaker A; Geertsma-Kleinekoort WM; Koenders JE; Kavelaars FG; Abbas ZG; Mahamoud S; Chu IW; Hoogenboezem R; Peeters JK; van Drunen E; van Galen J; Beverloo HB; Löwenberg B; Valk PJ
    Haematologica; 2014 May; 99(5):848-57. PubMed ID: 24441149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.
    Montefiori LE; Mullighan CG
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101329. PubMed ID: 34865701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic challenge of identifying cases with recurrent t(8;14)(q24.21;q32.2) Involving
    Bendig S; Stengel A; Walter W; Meggendorfer M; Baer C; Müller ML; Haferlach T; Kern W; Haferlach C
    Leuk Lymphoma; 2022 Mar; 63(3):747-750. PubMed ID: 34738838
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene.
    Bezrookove V; van Zelderen-Bhola SL; Brink A; Szuhai K; Raap AK; Barge R; Beverstock GC; Rosenberg C
    Cancer Genet Cytogenet; 2004 Feb; 149(1):72-6. PubMed ID: 15104287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.
    Ha VL; Luong A; Li F; Casero D; Malvar J; Kim YM; Bhatia R; Crooks GM; Parekh C
    Leukemia; 2017 Nov; 31(11):2503-2514. PubMed ID: 28232744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation.
    Botten GA; Zhang Y; Fuda F; Koduru P; Weinberg OK; Slone TL; Zheng R; Dickerson KE; Gagan JR; Chen W
    Br J Haematol; 2024 Aug; 205(2):607-612. PubMed ID: 38385580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
    Ehrlich LA; Yang-Iott K; Bassing CH
    Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia.
    MacLeod RA; Nagel S; Drexler HG
    Cancer Genet Cytogenet; 2004 Aug; 153(1):88-9. PubMed ID: 15325104
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of the transcription factor Bcl11b in development and lymphomagenesis.
    Kominami R
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):72-87. PubMed ID: 22450536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion.
    Oliveira JL; Kumar R; Khan SP; Law ME; Erickson-Johnson M; Oliveira AM; Ketterling RP; Dogan A
    Pediatr Blood Cancer; 2011 Mar; 56(3):467-9. PubMed ID: 21225930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.
    Nishimura A; Yokoyama K; Naruto T; Yamagishi C; Imamura T; Nakazono H; Kimura S; Ito M; Sagisaka M; Tanaka Y; Piao J; Namikawa Y; Yanagimachi M; Isoda T; Kanai A; Matsui H; Isobe T; Sato-Otsubo A; Higuchi N; Takada A; Okuno H; Saito S; Karakawa S; Kobayashi S; Hasegawa D; Fujisaki H; Hasegawa D; Koike K; Koike T; Rai S; Umeda K; Sano H; Sekinaka Y; Ogawa A; Kinoshita A; Shiba N; Miki M; Kimura F; Nakayama H; Nakazawa Y; Taga T; Taki T; Adachi S; Manabe A; Koh K; Ishida Y; Takita J; Ishikawa F; Goto H; Morio T; Mizutani S; Tojo A; Takagi M
    Sci Adv; 2023 Dec; 9(50):eadj4407. PubMed ID: 38091391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid.
    Wang W; Beird H; Kroll CJ; Hu S; Bueso-Ramos CE; Fang H; Tang G; Tang Z; Wang F; Takahashi K; You MJ; Khoury JD; Medeiros LJ; Futreal PA
    Leukemia; 2020 Sep; 34(9):2509-2512. PubMed ID: 32099038
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in Flow Cytometry for Mixed Phenotype and Ambiguous Leukemias.
    Kurzer JH; Weinberg OK
    Clin Lab Med; 2023 Sep; 43(3):399-410. PubMed ID: 37481319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
    Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
    Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
    Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
    J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma.
    Permatasari HK; Nakahata S; Ichikawa T; Fauzi YR; Kiyonari H; Shide K; Kameda T; Shimoda K; Ono M; Taki T; Taniwaki M; Futakuchi M; Morishita K
    Exp Hematol; 2022 Jul; 111():41-49. PubMed ID: 35421541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell of origin in radiation-induced premalignant thymocytes with differentiation capability in mice conditionally losing one Bcl11b allele.
    Go R; Hirose S; Katsuragi Y; Obata M; Abe M; Mishima Y; Sakimura K; Kominami R
    Cancer Sci; 2013 Aug; 104(8):1009-16. PubMed ID: 23663453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.